Researchers activate chemotherapeutics by ultrasound
Ultrasound that switches cancer drug on could significantly reduce chemotherapy side effects, German researchers found in preclinical studies.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1228 entries already.
Entries by Thomas Gabrielczyk
FAO presents food safety assessment on cell-based protein products
/in News/by Thomas GabrielczykAt the beginning of April, the FAO presented a report entitled "Food safety aspects of cell-based food" to establish safety standards for cell-based proteins.
Mosaic Therapeutics closes $28m series A financing
/in News/by Thomas GabrielczykWellcome Sanger Institute spin out Mosaic Therapeutics has closed a $28m series A funding led by Syncona Investment Management Ltd, and Cambridge Innovation Capital.
Carbios SAS set to licence and expand PET recycling
/in News/by Thomas GabrielczykFrench enzymatic polyethylene therephtalate recycler Carbios SAS has published a licensing documentation for global commercial deployment of its biorecycling technology.
Insempra and Axxence launch alpha-ionone
/in News/by Thomas GabrielczykPrecision fermentation specialist Insempra GmbH has inked a supply deal with Axxence Aromatic GmbH for alpha-Ionon, a natural flavour and fragance ingredient.
German-Chinese ADC collaboration
/in News/by Thomas GabrielczykBioNTech has entered the ADC field with an exclusive license and collaboration agreement with Chinas DualityBio Ltd for two antibody-drug conjugate (ADC) assets.
Nomi Biotech presents natural additive to preserve probiotics
/in News/by Thomas GabrielczykResearchers from Polish-Japanese Nomi Biotech sp zoo have presented evidence that that probiotic yogurt can be conserved without artificial preservatives.
LSP Dementia Fund closes at 260m
/in News/by Thomas GabrielczykEQT Life Sciences has closed the LSP Dementia Fund at approximately 260m, 2.6-fold over the target fund size of 100m.
Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals
/in News/by Thomas GabrielczykAntisense drug developer Secarna Pharmaceuticals and CNS expert SciNeuro Pharmaceuticals have inked an R&D and licence option contract for CNS diseases.
Hot of the press: new issue of BIOTECH Insight
/in News/by Thomas GabrielczykThe latest issue of BIOTECH Insight newsletter of Deutsche Börse in collaboration with BIOCOM AG is out, covering hot topics of the German biotech sector.